Humacyte Price To Sales Ratio vs Ptb Ratio Analysis

HUMAW Stock  USD 1.69  0.11  6.96%   
Humacyte financial indicator trend analysis is much more than just examining Humacyte latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Humacyte is a good investment. Please check the relationship between Humacyte Price To Sales Ratio and its Ptb Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.

Price To Sales Ratio vs Ptb Ratio

Price To Sales Ratio vs Ptb Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Humacyte Price To Sales Ratio account and Ptb Ratio. At this time, the significance of the direction appears to have weak relationship.
The correlation between Humacyte's Price To Sales Ratio and Ptb Ratio is 0.33. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Ptb Ratio in the same time period over historical financial statements of Humacyte, assuming nothing else is changed. The correlation between historical values of Humacyte's Price To Sales Ratio and Ptb Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Humacyte are associated (or correlated) with its Ptb Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ptb Ratio has no effect on the direction of Price To Sales Ratio i.e., Humacyte's Price To Sales Ratio and Ptb Ratio go up and down completely randomly.

Correlation Coefficient

0.33
Relationship DirectionPositive 
Relationship StrengthVery Weak

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Humacyte stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Humacyte sales, a figure that is much harder to manipulate than other Humacyte multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.
Most indicators from Humacyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Humacyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.Enterprise Value is likely to climb to about 284.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 21.1 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense4.3M6.2M1.1M1.1M
Depreciation And Amortization8.3M8.3M7.7M8.7M

Humacyte fundamental ratios Correlations

0.320.290.010.49-0.22-0.87-0.11-0.450.98-0.220.020.98-0.130.15-0.23-0.040.490.47-0.230.970.750.00.00.340.0
0.32-0.290.83-0.17-0.96-0.1-0.90.260.51-0.960.860.52-0.890.90.25-0.830.910.980.270.530.56-0.59-0.590.99-0.59
0.29-0.29-0.170.950.37-0.310.360.150.20.37-0.240.180.62-0.11-0.980.13-0.33-0.22-0.990.17-0.140.080.08-0.230.08
0.010.83-0.17-0.14-0.880.16-0.790.240.21-0.880.780.21-0.790.980.1-0.980.80.810.130.220.41-0.55-0.550.78-0.55
0.49-0.170.95-0.140.31-0.560.370.050.410.31-0.280.40.55-0.03-0.960.13-0.16-0.07-0.960.390.120.220.22-0.110.22
-0.22-0.960.37-0.880.31-0.080.96-0.2-0.41.0-0.91-0.410.95-0.89-0.360.9-0.9-0.93-0.37-0.42-0.480.710.71-0.940.71
-0.87-0.1-0.310.16-0.56-0.08-0.260.51-0.84-0.080.34-0.84-0.130.010.3-0.22-0.3-0.280.3-0.83-0.76-0.46-0.46-0.1-0.46
-0.11-0.90.36-0.790.370.96-0.26-0.34-0.270.96-0.98-0.280.91-0.79-0.370.85-0.76-0.82-0.39-0.29-0.250.860.86-0.890.86
-0.450.260.150.240.05-0.20.51-0.34-0.38-0.20.5-0.38-0.050.29-0.23-0.26-0.160.1-0.22-0.37-0.54-0.44-0.440.35-0.44
0.980.510.20.210.41-0.4-0.84-0.27-0.38-0.40.181.0-0.310.34-0.16-0.220.660.65-0.151.00.83-0.08-0.080.52-0.08
-0.22-0.960.37-0.880.311.0-0.080.96-0.2-0.4-0.91-0.410.95-0.89-0.360.9-0.9-0.93-0.37-0.42-0.480.710.71-0.940.71
0.020.86-0.240.78-0.28-0.910.34-0.980.50.18-0.910.19-0.820.790.24-0.850.660.760.250.20.11-0.9-0.90.87-0.9
0.980.520.180.210.4-0.41-0.84-0.28-0.381.0-0.410.19-0.320.34-0.14-0.220.660.65-0.131.00.83-0.09-0.090.52-0.09
-0.13-0.890.62-0.790.550.95-0.130.91-0.05-0.310.95-0.82-0.32-0.78-0.610.8-0.88-0.85-0.62-0.33-0.490.610.61-0.840.61
0.150.9-0.110.98-0.03-0.890.01-0.790.290.34-0.890.790.34-0.780.04-0.950.840.890.060.350.5-0.51-0.510.87-0.51
-0.230.25-0.980.1-0.96-0.360.3-0.37-0.23-0.16-0.360.24-0.14-0.610.04-0.090.310.191.0-0.130.12-0.14-0.140.19-0.14
-0.04-0.830.13-0.980.130.9-0.220.85-0.26-0.220.9-0.85-0.220.8-0.95-0.09-0.78-0.79-0.11-0.23-0.340.690.69-0.790.69
0.490.91-0.330.8-0.16-0.9-0.3-0.76-0.160.66-0.90.660.66-0.880.840.31-0.780.960.320.670.81-0.4-0.40.85-0.4
0.470.98-0.220.81-0.07-0.93-0.28-0.820.10.65-0.930.760.65-0.850.890.19-0.790.960.210.660.71-0.48-0.480.96-0.48
-0.230.27-0.990.13-0.96-0.370.3-0.39-0.22-0.15-0.370.25-0.13-0.620.061.0-0.110.320.21-0.120.14-0.14-0.140.21-0.14
0.970.530.170.220.39-0.42-0.83-0.29-0.371.0-0.420.21.0-0.330.35-0.13-0.230.670.66-0.120.84-0.09-0.090.53-0.09
0.750.56-0.140.410.12-0.48-0.76-0.25-0.540.83-0.480.110.83-0.490.50.12-0.340.810.710.140.840.140.140.50.14
0.0-0.590.08-0.550.220.71-0.460.86-0.44-0.080.71-0.9-0.090.61-0.51-0.140.69-0.4-0.48-0.14-0.090.141.0-0.621.0
0.0-0.590.08-0.550.220.71-0.460.86-0.44-0.080.71-0.9-0.090.61-0.51-0.140.69-0.4-0.48-0.14-0.090.141.0-0.621.0
0.340.99-0.230.78-0.11-0.94-0.1-0.890.350.52-0.940.870.52-0.840.870.19-0.790.850.960.210.530.5-0.62-0.62-0.62
0.0-0.590.08-0.550.220.71-0.460.86-0.44-0.080.71-0.9-0.090.61-0.51-0.140.69-0.4-0.48-0.14-0.090.141.01.0-0.62
Click cells to compare fundamentals

Humacyte Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Humacyte Stock Analysis

When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.